# Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease

Study · id `cardio:ct-nct01638832` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01638832](<https://clinicaltrials.gov/study/NCT01638832>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01638832

Browse, organ or system: Heart; Metabolism  
Browse, condition area: Coronary and vascular disease; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 572 participants.

## Technical summary

Registry record NCT01638832. Allocation not applicable; no masking; primary purpose diagnostic. Start 2012-06 (registry gives no type); primary completion 2013-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 572 participants (planned count; ClinicalTrials.gov record NCT01638832, source copy `cardio:ctgov-nct01638832-2012-07-12`, retrieved 2026-10-26)
- Start date: 2012-06 (registry gives no type) (ClinicalTrials.gov record NCT01638832, source copy `cardio:ctgov-nct01638832-2012-07-12`, retrieved 2026-10-26)
- Primary completion: 2013-09 (anticipated) (ClinicalTrials.gov record NCT01638832, source copy `cardio:ctgov-nct01638832-2012-07-12`, retrieved 2026-10-26)
- Completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01638832, source copy `cardio:ctgov-nct01638832-2012-07-12`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT01638832, source copy `cardio:ctgov-nct01638832-2012-07-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01638832-2012-07-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease
- Condition: Nonalcoholic Steatohepatitis (NASH)
- Intervention (Device): Transient Elastography (FibroScan), Echosens, Paris, France
- Intervention (Device): Controlled Attenuation Parameter (CAP), Echosens, Paris, France
- Lead sponsor: Johann Wolfgang Goethe University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Fatty liver disease (NAFLD / MASLD) (`cardio:nafld`)

## Provenance

Content hash: 3a4f28dd61b8cfb4ea6ba961769623f73306733664676fc607604582b4490188
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
